PERTINENT FINDINGS: We developed [123I]CC1—combining the biophysical properties of 123I, with its short-range Auger electron emissions, and a small molecule PARP inhibitor—to deliver a dense radiation dose close to cancer cells’ DNA. This evidence concerns the gene PARP1 and cancer.